Interleukin 10 (IL-10) and viral Ibl0 (v-IL-10) strongly reduced antigen-specific proliferation of human T cells and CD4 + T cell clones when monocytes were used as antigen-presenting cells. In contrast, IL-10 and v-Ibl0 did not affect the proliferative responses to antigens presented by autologous Epstein-Barr virus-lymphoblastoid cell line (EBV-LCL). Inhibition of antigen-specific T cell responses was associated with downregulation of constitutive, as well as interferon 3'-or Ib4-induced, class II MHC expression on monocytes by IL-10 and v-Ibl0, resulting in the reduction in antigen-presenting capacity of these ceUs. In contrast, IL-10 and v-Ibl0 had no effect on class II major histocompatibility complex (MHC) expression on EBV-LCL. The reduced antigenpresenting capacity of monocytes correlated with a decreased capacity to mobilize intracellular Ca 2 + in the responder T cell clones. The diminished antigen-presenting capacities of monocytes were not due to inhibitory effects of II.-10 and v-Ibl0 on antigen processing, since the proliferative T cell responses to antigenic peptides, which did not require processing, were equaUy well inhibited. Furthermore, the inhibitory effects of Ibl0 and v-IL-10 on antigen-specific proliferative T cell responses could not be neutralized by exogenous Ib2 or Ib4. Although IL-10 and v-IL-10 suppressed IL-lc~, IL-1B, tumor necrosis factor ot (TNF-c~), and IL-6 production by monocytes, it was excluded that these cytokines played a role in antigen-specific T cell proliferation, since normal antigenspecific responses were observed in the presence of neutralizing anti-Ibl, -IL-6, and -TNF-tx mAbs. Furthermore, addition of saturating concentrations of IL-lot, IL-I~, IL-6, and TNF-o~ to the cultures had no effect on the reduced proliferative T cell responses in the presence of Ibl0, or v-Ibl0. Collectively, our data indicate that IL-10 and v-IL-10 can completely prevent antigen-specific T cell proliferation by inhibition of the antigen-presenting capacity of monocytes through downregulation of class II MHC antigens on monocytes.
M
urine IL-10 (m-IL-10) 1 cytokine synthesis inhibitory factor (CSIF) is produced by Th2 cells and inhibits the synthesis of cytokines, particularly of IFN-y, by Thl, but not Th2 cells (1) . This inhibitory activity on cytokine production by IL-IO was found to be indirect and required the presence of APC (1, 2) . In addition, it was demonstrated that cytokine production by Thl clones was affected only when macrophages, but not purified conventional or Lyl + 1 Abbreviations used in this paper: CSIF, cytokine synthesis inhibitory factor; FMF, flow microfluorimetry; hsp, heat shock protein; m, murine; TT, tetanus toxoid; v, viral.
B cells, were used as APC (2) . It was shown that m-Ibl0 has multiple biological activities. II.,10 has mast cell growth factor activity in combination with IL-3 and/or Ib4 (3), and T cell growth factor activity on mature and immature mouse thymocytes in the presence of Ib2 and IL-4 (4). In addition, m-Ibl0 increased the expression of class II MHC antigens on small murine splenic B cells and enhanced the viability of these cells (5) . Furthermore, m-Ibl0 was shown to be produced by murine Ly-1 + B ceils and B cell lymphomas and may act as an autocrine growth factor for these cells (6) .
Recently, the cDNA encoding for human Ibl0 was cloned from a cDNA library made from a tetanus toxin (TT)-specific CD4 + T cell clone that produced multiple cytokines after activation, including II.-2, IFN-% II.-4, and 11:5, indicating that this clone does not fit the Thl or Th2 subsets (7). Human I1.-10 and m-IL,10 exhibit extensive sequence homology to a previously uncharacterized open reading frame in the EBV genome, BCP, F-1 (7, 8) . It was shown that both I1:10 and the protein product of BCKF-1, designated viral-I1:10 (v-Ib 10), exhibited cytokine synthesis inhibitory activity on antigenspecific mouse T cell clones and human PBMC activated by antigen and macrophages or PHA and anti-CD3 mAbs, respectively (7, 9). However, v-Ibl0 had little murine mast cell stimulatory activity or thymocyte growth factor activity, and it did not affect class II MHC expression on mouse splenic B cells (3, 5). In the present study, the effects of I1:10 and v-Ibl0 on antigen-specific human T cell responses were investigated. It was shown that I1:10 and v-I1:10 strongly blocked the antigen-specific proliferative responses of both T cells and CD4 + Thl-or Th2-1ike T cell clones. The inhibitory effects on antigen-specific T cell proliferation were only observed when monocytes, but not when EBV-LCL were used as APC. In addition, it is shown that Ibl0 and v-ILl0 have strong downregnlatory effects on both constitutive and I1:4-or IFN-"y-induced class II MHC expression on monocytes, indicating that the strongly reduced proliferative T cell responses towards antigens are due to inhibition of antigen-presenting capacity of monocytes through downregnlation of class II MHC antigens on these cells.
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Materials and Methods
Cells and Reagents. The TT-specific T cell clone 827 (14) , the T cell clones NP12, NP14, and NP44, which are specific for the major allergen in house dust, Derp I (Yssd et al., manuscript submitted for publication), and the 65-kD M. leprae hsp-specific T cell clones HY06, Kp1511, R2F10, and CAAp1515 (13, 15) have all been described previously. T cell clones (2 x los/m1) were stimulated at 2-wk intervals by a feeder cell mixture consisting of 10fire1 irradiated (4,000 tad) allogeneic PBL, los/ml irradiated (5,000 tad) cells of the EBV-transformed B cell line (EBV-LCL) JY, and 0.1 #g/ml purified PHA (Wellcome Diagnostics, Beckenham, Kent, UK) as described (14) and expanded by addition of riD2. The EBV-LCL HSY, which was established from the same donor as T cell clones 827 and HY06 (14) , NPR, which was derived from the same donor as T cell clones NP12, NP14, and NP44 (Yssel et al., manuscript submitted for publication), and PZB (15) , which was HLA-DR identical to the tuberculoid leprosy patieut from whom the T cell clones Rp1511 and R2F10 were derived, have been described. T cell clones and EBV-LCL were cultured in Yssel's medium (14) supplemented with 1% human AB + serum. TT was generously provided by Dr. Bizzini (Institute Pasteur, Paris, France).
The Derla I cDNA clone was kindly provided by Dr. W. Thomas (Princess Margaret Hospital, Perth, Australia). Recombinant Der p I antigen was expressed in Escherichia coil and purified (16) . M. leprae antigen (CD104) was a kind gift of Dr. R. J. W. Rees (London, UK). The Der p 1-specific peptide (amino acids and M. leprae 65-kD hsp peptides (amino acids 3-13 and 418-427) were made by solid phase peptide synthesis and checked by analytical reverse phase HPLC and amino acid analysis (17) . M. lepraespecific peptides were kindly provided by Dr. D. C. Anderson (University of Washington, Seattle, WA).
Recombinant IL-10 and v-IL-10 were expressed in E. coli and purified (16) . Purified human r-IL-4 and IFN-y were provided by Schering-Plough Research (Bloomfield, NJ). The neutralizing mAb 19F1 recognizing both h-II.d0 and v-IIA0 has been described (J. Abrams et al., manuscript in preparation).
Isolation and Culture of Human Monocytes. Human peripheral blood monocytes were isolated from 500-ml blood samples from normal donors as described previously (18, 19) . The monocyte preparation was over >95% pure, as judged by nonspecific esterase staining, and contained >98% viable cells. Monocytes were cultured in Yssel's medium (14) containing HSA supplemented with 1% pooled heat-inactivated human AB + serum. This culture medium was endotoxin free as determined by the Limulus amebocyte lysate assay (< 0.2 ng/ml endotoxin). The monocytes were cultured at a concentration of 4 x 10 ~ cells/ml in teflon bags (Jansen MNL, St. Niklaas, Belgium) and, where indicated, IFN-3, (100 U/ml), ID4 (100 U/ml), or TT (0.5 #g/ml) was added. Immunofluorescence Analysis. Cells (10 s) were incubated in V-bottomed microtiter plates (Flow Laboratories) with 10 #1 of purified mAb (1 mg/ml) for 30 rain at 4~ After two washes with PBS containing 0.02 mM sodium azide and 1% BSA (Sigma Chemical Co., St. Louis, MO), the cells were incubated with 1:40 dilution of FITC-labeled F(ab')2 fragments of goat anti-mouse antibody (Tago, Inc., Burlingame, CA) for 30 min at 4~ After three additional washes, the labeled cell samples were analyzed by flow microfluorimetry (FMF) on a FACScan | (Becton Dickinson & Co., Sunnyvale, CA). The anti-MHC class II mAbs PdV5.2 (HLA-DR/ DP/DQ) (20) , Q5/13 HLA-DK/DP (21), SPV-L3 (HLA-DQ) (14) , and anti-CD3 (SPV-T3b) (14) were described previously).
Ca 2 § Flux Measurements. T Cells at 107/ml were loaded with Indo-1 by incubation with its acetoxymethyl ester (Molecular Probes, Junction City, OK) at a concentration of 1 #M for 45 rain at 37~ Cells were washed once and resuspended in flesh medium at 106 ceUs/ml and stored at room temperature in the dark until tested. 
Results
h-ILlO and v-ILlO Inhibit Antigen-specific Proliferation of T Cells.
To determine the effect of Ibl0 on antigen-specific proliferation of human T cells, purified T cells obtained from donors immunized with TT were stimulated with TT and autologous purified monocytes. In Fig. 1 , it is shown that both IL-10 and v-Ibl0 inhibited TT-specific proliferative responses of the T cells in a dose-dependent fashion. Significant inhibitory effects were already observed at Ibl0 concentrations of 10 U/ml, whereas maximal inhibition was obtained at 100 U/m1. These results indicate that specific proliferative responses of human T cells to soluble antigen are reduced by IF10 and v-IL-10 when monocytes are used as APC. Furthermore, it is shown in Table 1 that preincubation of the monocytes for 24 h with IL-10 (100 U/m1) or v-IL-10 (100 U/ml), followed by incubation of these cells in the presence of purified T ceils and TT (in the absence of IF10), resulted in 50% reduction in the proliferative responses, as compared to the TT-specific proliferative responses of these T cells when cocultured with monocytes preincubated in medium alone. Addition of IL-10 or v-IL-10 to the cultures of T cells, TT, Peripheral blood T cells and monocytes were isolated by centrifugal dutriation and cultured in the absence or presence of IL-10 (100 U/ml) and v-IL-10 (100 U/ml). Monocytes (2 x 104/well) were added directly to the T cells (5 x 104/well), or after preincubation for 24 h in medium, IL-10 (100 U/ml), or v-IL-10 (100 U/ml). TT was added at 0.5 #g/ml).The SD was <10% in all tests.
and monocytes preincubated with Ibl0 or v-II.-10 abolished the TT-specific proliferative responses of purified T cells almost completely. These results indicate that ILl0 primarily acts on the antigen-presenting capacity of monocytes.
11_,10 and v-ILlO Reduce Proliferative
Responses of Antigenspecific T Cell Clones. IL-10 and v-IL-10 also inhibited in a dose-dependent way the proliferative responses of the TTspecific T cell clone 827, the Der p I-specific T cell clone NP14, and the T cell clone HY06, which is specific for the antigenic peptide 3-13 of the 65-kD M. leprae hsp, when monocytes were used as APC. As shown in Fig. 2 , 10 U/ml of II.-10 or v-Ibl0 was sufficient to reduce antigen-specific responses by 50-70%, and maximal inhibition was observed at 100 U/ml. However, 11.-10 and v-ILl0 did not affect antigenspecific proliferative responses of these and several other antigen-specific CD4 + T cell clones when autologous EBV-LCL were used as APC. The anti-ILl0 mAb 19F1 completely neutralized the reduced responsiveness observed in the presence of ILl0, demonstrating the specificity of the inhibition (Table 2 ). II.-10 and v-IL-10 also inhibited the proliferative responses towards antigenic peptides that do not require antigen processing as shown (Fig. 1, Table 2 ). The proliferation of the Der p I-specific T cell clones NP12, NP14, and NP44 in response to both the whole Der p I and the Der p I-derived peptide 89-117 was strongly reduced by II:10 and v-ILl0. Similar results were obtained with T cell clone Rp1511, which is specific for the 65-kD hsp ofM. leprae. Proliferation of this clone in response to both the whole M. leprae antigen, or the 65-kD hsp derived peptide 3-13 is blocked for 90% by IL-10 (100 U/ml) and v-Ibl0 (100 U/ml). The prolifera- tive responses of the CD4 § T cell clones HY06, CAAp1515, and R2F10, which are specific for the 65-kD hsp-derived peptides 3-13 or 418-427 and were established from different donors, were also strongly inhibited by IL-10 and v-IL-10. Again, IL-10 and v-IL-10 had no affect on the antigen-specific proliferative responses when the peptides were presented by autologous EBV-LCL.
The Inhibition of T Cell Proliferation by IL.IO and v-ILlO Is
Dependent on Antigen Concentration. In Fig. 3 , it is shown that the degree of reduction of the proliferative responses of the Der p I-specific T cell clones NP14 and NP44 by IL-10 and v-IL-10 depended on the antigen concentration. NP14 and NP44 activated by the Der p I-derived peptide 89-117 at concentrations varying from 0.01 to 10/xg/ml, and monocytes as APC showed the same degree of proliferation (Fig.  3) . Although IL-10 and v-Ibl0 significantly reduced the proliferative responses at peptide concentrations of 10 #g/ml, the reduction of the proliferative responses increased further at lower peptide concentrations. More than 90% reduction of the proliferative responses was observed when the Der p I-derived peptide was used at 0.01/zg/ml, a concentration that still resulted in maximal proliferative T cell responses.
These results indicate that the reduced proliferation observed in the presence of IL-10 is particularly pronounced when the antigen concentration becomes more limited.
IL-IO and v-IL-lO Strongly Downregulate Class II MHC Membrane Expression on Monocytes but Not on EBVLCL.
The results obtained thus far suggest that IL-10 and v-IL-10 reduce the effectiveness of monocytes as APC. Antigen-presenting capacity of APC has been shown to depend, among other factors, on the density of class II MHC molecules accommodating the relevant antigenic peptides (22) . Therefore, the effects of IL-10 and v-IL-10 on constitutive HLA-DR and HLA-DQ expression on monocytes were investigated. HLA-DK expression on human monocytes increases during culture of these cells, even after incubation in teflon culture bags, which prevents adhesion of the cells (Fig. 4) (23) . In Fig. 4 , it is furthermore shown that II.-10 strongly downregulated this increased HLA-DR expression on human monocytes. IL-10 (100 U/ml) reduced the constitutive HLA-DR expression by 90% after 40 h of culture. These results were confirmed by using several anti-class II MHC mAbs, specific for HLA-DK/DP or HLA-DK alone (not shown). Dose-response studies indicated that inhibitory effects on HLA-DR expression were already observed at IL-IO concentrations of 1 U/ml. The con- T cell clones (2 x 104/well) and monocytes (104/well) or autologous EBV-LCL (2 x 104) were cultured in the presence of IL-10 (100 U/ml) or v-IL-10 (100 U/ml) for 72 h. Neutralizing anti-IL-10 mAb 19F1 was added at a concentration of 10 #g/ml. r-Der p I and the Der p l-derived peptide 89-117 were added at concentrations of 1/~g/ml. M. leprae and M. leprae 65-kD hsp-derived peptide 3-13 were added at 1 and 0.5/~g/ml, respectively. The SD was <10% in all tests. stitutive expression of HLA-DQ, which is much lower than that of HLA-DR, was also strongly downregulated by IL-10. Identical results on downregulation of class II MHC expression were obtained with v-IL-10 (not shown). Interestingly, IL-10 and v-IL-10 also strongly blocked the enhanced HLA-DR and HLA-DQ expression induced by IL-4 (100 U/ml) or IFN-3, (100 U/ml). The dose-response curves shown in Fig. 5 for HLA-DR indicate that IL-10 seems to be more effective in counteracting the class II MHC enhancing effect of IFN-3, than that of II.,4. In contrast, IL-IO and v-IL-10 failed to affect constitutive HLA-DR and HLA-DQ expression on various EBV-LCL, as shown for NPR in Fig. 6 .
II.,10 Affects the Capacity of Monocytes to Present Antigens as Reflected by Reduced Ca 2+ Fluxes in the T Cell Clones, If the reduction in class II MHC expression on monocytes by
IL-IO accounts for the strongly reduced antigen-specific proliferative responses, this would imply that we are dealing with a reduced capacity to induce T cell activation. If this conclusion is correct, reduced stimulatory capacity of monocytes as APC should be reflected in reduced induction of Ca 2 + mobilization in the responding T cell clones. In Fig.  7 , it is shown that Ca 2 § fluxes induced in T cell clone 827 were suppressed by "~70% when monocytes preincubated with TT and IL-10 were used to activate the T cell clone. Ca 2 + fluxes induced by an anti-CD3 mAb were used as con- trois. In the presence of I1,10, but in the absence of monocytes, no changes were observed in the Ca 2+ fluxes of the T cell clone in response to anti-CD3 mAbs. However, when monocytes, preincubated with TT in the presence of I1,10, were added to the T cell clones, strong reductions in both the plateau levels of the Ca 2+ fluxes and the percentage of positive cells were observed, as compared to the Ca 2+ fluxes induced by monocytes that were preincubated with TT alone. It has to be noted that Ca 2 + fluxes could be measured at the earliest 3-4 rain after addition of the monocytes to the T cells, because a 2-min centrifugation step was required in order to establish optimal T cell/APC contacts.
Reduced Antigen-specific T Cell Proliferation Induced by 11,10 and v-I1,I0 Cannot be Neutralized by Exogenous 11,2 or 11,4.
The results thus far suggest that the reduced proliferative responses of the T cell clones observed in the presence of I1,10 and v-Ibl0 are related to a reduced capacity of monocytes to present antigen, which leads to an incomplete activation of the T cell done. Since II.-10 has cytokine synthesis inhibitory (CSI) activity (de Waal Malefyt et al., manuscript in preparation), the effects of I1.-2 and II.-4 on the inhibition of antigen-specific proliferative responses were examined. In Fig. 8 , it is shown that I1,10 and v-I1,10 inhibited the antigenspecific response of T cell clone 827 to TT with monocytes as APC by 85-90%. The addition of increasing amounts of I1,2 to these cultures resulted in enhanced proliferative responses, both in the presence or absence of I1,10, until a plateau was reached at concentrations of 1,000 U/ml. Addition of I1,2 at concentrations of up to 100 U/ml, which is suf~cient to saturate high ai~nity I1,2Rs, had no effect on the inhibition of antigen-spedfic T cell proliferation by I1,10. Even at I1,2 concentrations of >1,000 U/ml, still 30-40% inhibi- IntraceUular Ca 2+ concentrations were measured in T cell clone 827 in response to anti-CD3 mAb, anti-CD3 mAb + Ibl0 (100 U/ml), monocytes preincubated with TT (0.5 #g/ml), and monocytes preincubated with TT and Ibl0 (100 U/ml). Anti-CD3 mAbs were added at 0 rain. T cells and monocytes were centrifuged for 2 rain to establish cell-cell contacts, gently resuspended, and analyzed on the FACS | tion was observed. These results indicated that inhibition of I1,2 production, due to the CSI activity of II.-10, could only partially account for the inhibition of antigen-specific proliferation of T cell clone 827. Furthermore, it is shown in Fig.  8 that monocytes and high concentrations of IL-2 were able to induce proliferation of the T cell clones in the absence of antigen. These responses were also inhibited by I1,10. However, the proliferative responses of T cell clone 827 to Ib2 in the absence of monocytes were, as expected, not affected by 11.-10. Identical results were obtained with v-I1,10 (not shown). Addition of increasing amounts of I1,4 to the T cell clone 827 activated by TT and monocytes as APC completely failed to affect the antigen-specific proliferative responses, either in the absence or in the presence of IL-10 and v-I1,10 (not shown). This indicated that Ib4 was not involved in the I1,10-mediated inhibition of antigen-specific proliferation of this T cell done. Expression of IL-2Rot or I1,2RB chains of T cell clones that were cultured for up to 72 h in the presence of I1,10 or v-lbl0 was not modulated (not shown). Collectively, these data indicate that reduced antigen-presenting capacity of monocytes caused by I1,10-mediated downregulation of class II MHC expression leads to incomplete activation of the T cell clones that can only be partially rescued by very high concentrations of exogenous I1,2, but not by I1,4.
Discussion
Ibl0 and its viral counterpart, v-IL-10, can completely prevent the specific proliferative responses of CD4 + T cells and CD4 + T cell clones towards various protein antigens and antigenic peptides. Reduced antigen-specific proliferative responses were observed only when monocytes, and not when autologous or allogeneic EBV-LCL carrying the appropriate restriction elements, were used as APC. These results are in line with observations made in murine systems where Horentino et al. (2) showed that II=10 inhibited IFN-'y production by mouse T helper cell clones when monocytes, but not when B cells, were used as APC. Interestingly, the reduced responsiveness was partially restored by exogenous II,2, but only at very high concentrations of >1,000 U/ml, suggesting that the reduced proliferation observed in the presence of IL-10 and v-IL-10 under the present culture conditions was not a mere consequence of inhibition of endogenous I1.-2 production, due to CSI activity of I1,10 or v-I1,10. This observation is compatible with murine studies that have indicated that m-I1,10 (CSIF) had only weak inhibitory effects on I1,2 production by Thl cells after activation by antigen presented by maerophages (1). In addition, these studies showed that m-IL-10 still suppressed the production of IFN-y by Thl dones when these experiments were performed in the presence of saturating quantities of Ib2 (1). Ibl0 and v-Ibl0 also re- duced the proliferative responses to antigenic peptides, which do not require processing (24, 25) , indicating that the inhibitory effects of II:10 and v-Ibl0 are not related to inhibition of antigen processing by the monocytes. Comparable data were obtained in routine studies that demonstrated that m-Ibl0 also reduced cytokine production after activation by superantigens that do not require processing (2) . Murine studies furthermore indicated that m-IL-10 suppressed lymphokine production by Thl cells (1) . Human CD4 + T cell clones cannot generally be divided in Thl or Th2 subsets (11, 12) . However, the Derp I-specific T cell clones have been shown to produce very high levels of Ib4 and IL-5 and low to normal levels of Ib2 and IFN-% Because of these aberrant IL-4/IFN-',/production ratios, these clones were designated as "Th2-1ike" cells (Yssel et al., manuscript submitted for publication). In contrast, the M. lelorae-specific T cell clones produced unusually high levels of IFN-% and undetectable or very low levels of Ib4 and IL-5, and were therefore considered to represent "Thl-like" cells (13) . Although these clones do not fully represent murine Thl or Th2 cells, it is of interest to note that IL-10 and v-IL-10 inhibited the proliferation of both the Der p I-and the M. leprae-specific clones equally well. IL-10 and v-IL-10 strongly downregulated constitutive class II MHC expression on human monocytes. IL-10 and v-IL-10 not only downregulated constitutive class II MHC expression, but also blocked the class II MHC enhancing effects of IFN-"/and IL-4 in a dose-dependent fashion. I1.-10 and v-Ibl0 failed to modulate class I MHC expression on monocytes and did not affect the levels of CDlla, CD11b, CDllc, CD18, CD54 (ICAM-1), CD58 (LFA-3), CD14, CD44, VLA-4, VLA-5, VLA-6, CD23, and CD25 (results not shown). These results indicate that the reduction in the antigen-presenting capacity of monocytes is not due to inhibition of intercellular adhesion molecules that either directly (26, 27) , or by mediating T cell APC contacts, play an important role in T cell activation and proliferation. The observation that the APC function of EBV-LCL was not affected by II:10 and v-IL-10 tested over a wide concentration range and after prolonged incubation times (up to 4 d), together with the fact that IL-10 and v-Ibl0 failed to downregulate class II MHC expression on these cells, suggested that the reduction in antigen-specific proliferative responses of CD4 + T cells and T cell clones could be associated with the strong reduction in surface class II MHC expression on the monocytes. Harding & Unanue (28) recently have shown that '~300 class II MHC-specific antigenic peptides complexes on APC representing only 0.1-0.2% of the restricting class II MHC molecules were sufficient to induce T cell proliferation. Their studies furthermore indicated that most class II MHC molecules were not occupied by the antigenic peptide, but probably by self or other antigenic peptides (28) . Such a very low percentage of class II MHC molecules accommodating the specific peptides may account for the observation that the proliferative responses were reduced by >90%, whereas there was still considerable surface class II MHC expression on the monocytes. In addition, it was shown recently that antigenic peptides need to associate with newly synthesized HLA-DR molecules before cell surface expression (29, 30). Recycling of class II MHC molecules (31) , or association of peptides with "empty" class II MHC molecules expressed on the cell surface, do not significantly contribute to the expression of immunogenic class II MHC peptide complexes (29-31). This suggests that class II MHC synthesis and cell surface expression of new MHC class II/peptide complexes is particularly important for antigen presentation. It is possible that this process is downregulated by IL-10. This notion is further supported by the observation that reduction of the proliferative responses was more pronounced when the antigen concentration became limiting. From these observations, it can be concluded that IL-10 and v-IL-10 in these culture systems do not act as suppressor factors, but that the reduction in antigenspecific T cell proliferation in the presence of monocytes as APC merely reflects a strong reduction in the antigenpresenting capacity of these cells. This contention was compatible with the observations that the [Ca2+]i fluxes were strongly reduced when the TT-specific T cell clones were stimulated by monocytes preincubated with TT in the presence of IL-10 or v-IL-10 and that neither IL-2-induced proliferation nor the expression of IL-Roe and ID2R3 chains on the T cell clones was affected by IIA0 and v-IL-10.
More recently, we have demonstrated that IL-10 and v-IL-10 strongly inhibit the production of IL-lo~, IL-13, II,-6, I1.-8, TNF-oe, and granulocyte/macrophage (GM)-CSF (31a). II.~loe, IL-13, and also Ib6, TNF-c~ and GM-CSF have been shown to have costimulatory effects on antigen-specific T cell proliferation (32) (33) (34) (35) . However, it was excluded that the strong reduction in antigen-specific proliferative responses was due to inhibition of the production of these monokines, because reduced responsiveness could not be neutralized by addition of saturating concentrations of these monokines. In addition, it was demonstrated that under the present culture conditions, antibodies against these monokines did not decrease the antigen-specific proliferative T cell responses (not shown). It was also ruled out that II~10 induced the production of TGF-~ (36), or other unknown soluble suppressor factors by monocytes. Supernatants of cultures in which strong reduction in T cell proliferation was obtained in the presence of monocytes, TT, and IL-10, failed to affect the specific proliferative responses of T cell clones induced by TT presented by autologous EBV-LCL (not shown). Furthermore, freshly isolated monocytes added in relatively high concentrations to cultures of TT-specific T cell clones, TT, and autologous EBV-LCL as APC failed to reduce the proliferative responses of these clones in the presence of IL-10, indicating that IL-10 did not induce these "bystander" monocytes to release factors suppressing antigen-specific T cell proliferation. In addition, supernatants of monocytes cultured in the presence or absence of IL-10 and tested in the presence of the neutralizing anti-IL-10 mAb failed to enhance the TT-specific proliferative responses of T cell clones suboptimally activated by TT and autologous EBV-LCL. This argues against the idea that IL-10 could suppress the production of a putative soluble monocyte factor, which has costimulatory activity on antigen-specific T cell proliferation.
Collectively, our data indicate that both-10 and v-IL-10 through downregulation of class II MHC molecules on monocytes strongly reduce the antigen-presenting capacity of these cells, thereby reducing, or preventing, optimal antigen-specific proliferative T cell responses. Recently, we have shown that monocytes stimulated by LPS produce I1:10. However, I1:10 is produced late (24-36 h) after activation (31a), whereas I1:1ol, 11-13, II:6, and TNF-ol are generally maximally produced after 8-12 h of activation (37) . These kinetics of I1:10 production by monocytes, together with its inhibitory effects on proinflammatory monokine production and its downregulatory effects on class II MHC molecules, suggest that I1:10 in an autocrine fashion may play a role in damping immune responses.
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